Local Time
English (UK) Deutsch (DE) Français (FR) Español (ES) Italian (IT)
Corix Bioscience Announces New Tissue Culture and Research Lab
Author: Bryan Mc Govern  11/08/2017 - 15:56:00

Corix Bioscience (OTCQB:CXBS) announced they will move the tissue cell culture and research divisions into a new Nevada facility. 

As quoted in the press release: 

This move will enable Corix to produce over 3 million plantlets in the immediate future and set them up to double that in the second full year. This new laboratory will be the first known tissue culture facility focused exclusively on the hemp and cannabis market. Until now, Corix relied on outside suppliers for seeds and clones. This will bring all propagation in-house. Part of the laboratory will be dedicated to the research of their proprietary CBD products and will require adding about 8 new employees. 

Michael Ogburn, CEO of Corix Bioscience Inc., stated, “Moving into this new facility is going to give us the room we need to keep up with our aggressive expansion. We expect to produce over 750,000 plantlets just for ourselves next spring and sell the remaining 2.2 million plants on the wholesale market adding a potential $8 million in revenue. We also needed the space for the ongoing breeding of new strains for the medical industry’s ever-growing needs we’re seeing firsthand as the first major player for applications for cancer, the opioid epidemic, and other illnesses and diseases looking for treatments from the CBD oil.”

Click here to read the full press release.

The post Corix Bioscience Announces New Tissue Culture and Research Lab appeared first on Investing News Network.

Original article from cannabisinvestingnews.com:Corix Bioscience Announces New Tissue Culture and Research Lab


06/07/2018 - 15:01:00
Total pages / language:   36'395 / 21'868
In the archive :   46'558
Pages last 24 hours:   40
This Month Pages:   686
Views:   12'484'7302'153'514
Views Archive:   13'445'671

©2018 - Hempyreum.org - News aggregator about Hemp and Cannabis [Beta] | All rights and ownership of the contents belong to their respective holders